All In MedTech

FDA Clearance Tracker · K171868

A1AT Genotyping Test

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 21, 2026Latest source record: Nov 11, 2017 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

The decision

FDA number
K171868
Device name
A1AT Genotyping Test
Applicant location
Derio, ES
Received
Jun 22, 2017
Decided
Nov 11, 2017
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 866.5130

Every decision under product code PZH

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code PZH (Serpina1 Variant Detection System).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Progenika Biopharma S.A., A Grifols Company

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.